Rapid Micro Biosystems (RPID) EBITDA (2020 - 2026)

Rapid Micro Biosystems' EBITDA history runs 7 years deep, the most recent figure standing at -$13.9 million for Q1 2026.

• In Q1 2026, EBITDA fell 18.79% year-over-year to -$13.9 million; the TTM figure through Mar 2026 stood at -$49.6 million (down 4.81% YoY), while the FY2025 annual figure was -$47.4 million, up 5.06% from the prior year.
• EBITDA came in at -$13.9 million for Q1 2026 at Rapid Micro Biosystems, down from -$12.2 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of -$10.2 million in Q4 2024 to a low of -$17.3 million in Q4 2022.
• A 5-year average of -$13.6 million and a median of -$13.9 million in 2026 frame the typical range for EBITDA.
• Across the five-year window, EBITDA sank 54.77% in 2022 and increased 29.39% in 2023, its largest moves.
• Rapid Micro Biosystems' EBITDA stood at -$17.3 million in 2022, then increased by 29.39% to -$12.2 million in 2023, then rose by 16.07% to -$10.2 million in 2024, then retreated by 19.38% to -$12.2 million in 2025, then slipped by 13.44% to -$13.9 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$13.9 million, -$12.2 million, and -$11.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison